Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...
Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback